Lalatsa, Katerina

Schatzlein, Andreas G.

Uchegbu, Ijeoma F.

English

Name not available

Strategies to deliver peptide drugs to the brain

Portsmouth University Research Portal (Pure)

2010 Development trends for peptide therapeutics: A comprehensive quantitative analysis of peptide therapeutics in clinical development.&quot;

A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue. Sci Transl Med

A direct in vitro demonstration of insulin binding to isolated brain microvessels. Diabetes

A nose-brain pathway for psychotropic peptides: evidence from a brain evoked potential study with cholecystokinin. Psychoneuroendocrinology

A novel opportunity for targeted drug delivery to the brain.

A prodrug nanoparticle approach for the oral delivery of a hydrophilic peptide, leucine(5)-enkephalin, to the brain. Mol Pharm

A saturable mechanism for transport of immunoglobulin G across the blood-brain barrier of the guinea pig. Exp Neurol

ANG2002: A new Angiochem-modified neurotensin with increased brain penetration and analgesic properties (374.11/QQ6).

Anorectic effects of circulating cytokines: role of the vascular blood-brain barrier. Nutrition

Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2. Br J Pharmacol

Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis. J Pharmacol Exp Ther

Applications of a blood–brain barrier technology platform to predict CNS penetration of various chemotherapeutic agents. 2. Cationic peptide vectors for brain delivery. Chemotherapy

Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases. Neurobiol Dis

Attenuation of kindled seizures by intranasal delivery of neuropeptide-loaded nanoparticles. Neurotherapeutics

B6 Peptide-Modified PEG-PLA Nanoparticles for Enhanced Brain Delivery of Neuroprotective Peptide. Bioconjug Chem

Binding and internalization of insulin and insulin-like growth factors by isolated brain microvessels. Diabetes

Boado Agents for blood-brain barrier delivery.

Boado Fusion proteins for blood-brain barrier delivery.

Boado Fusion proteins for delivery of GDNF to the CNS.

Boado Methods and compositions for increasing alpha-iduronidase activity in the CNS

Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration.

Brain potential changes after intranasal vs. intravenous administration of vasopressin: evidence for a direct nose-brain pathway for peptide effects in humans.

Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? Nanomedicine (Lond)

Cell-penetrating peptides: from molecular mechanisms to therapeutics.

Central nervous system effects of intranasally administered insulin during euglycemia

Change in membrane permeability induced by protegrin 1: implication of disulphide bridges for pore formation.

Chapter 7.1: Nanostructures Overcoming the Blood-Brain Barrier: Physiological Considerations and Mechanistic Issues In Nanostructured Biomaterials for Overcoming Biological Barriers,

Characterization and modulation of the transferrin receptor on brain capillary endothelial cells. Pharm Res

Chemical optimization of new ligands of the low-density lipoprotein receptor as potential vectors for central nervous system targeting.

CNS delivery via adsorptive transcytosis.

Coaxing the LDL receptor family into the fold. Cell

Comparison of five different targeting ligands to enhance accumulation of liposomes into the brain.

Delivery of analgesic peptides to the brain by nano-sized bolaamphiphilic vesicles made of monolayer membranes.

Delivery of peptide and protein drugs over the blood-brain barrier. Prog Neurobiol

Delivery of peptides to the blood and brain after oral uptake of quaternary ammonium palmitoyl glycol chitosan nanoparticles.

Delivery of peptides to the blood and brain after oral uptake of quaternary ammonium palmitoyl glycol chitosan nanoparticles. Mol Pharm

Design of nanostructured biological materials through self-assembly of peptides and proteins.

Designing peptide based nanomaterials. Chem Soc Rev

Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26. Bioconjug Chem

Development of protegrins for the treatment and prevention of oral mucositis: structure-activity relationships of synthetic protegrin analogues. Biopolymers

Differential sensitivity of men and women to anorexigenic and memoryimproving effects of inranasal insulin.

Diphtheria toxin receptor-targeted brain drug delivery.

Double-coated poly (butylcynanoacrylate) nanoparticulate delivery systems for brain targeting of dalargin via oral administration.

Drug Delivery across the Blood-brain barrier.

Drug Targeting system, method of its preparation and its use.

Drug transport across the blood-brain barrier.

Effect of size and charge on the passive diffusion of peptides across Caco-2 cell monolayers via the paracellular pathway. Pharm Res

Efficacy of oral dalargin-loaded nanoparticle delivery across the blood-brain barrier. Peptides

Enhanced brain delivery of the opioid peptide DAMGO in glutathione pegylated liposomes: a microdialysis study. Mol Pharm

Enhanced oral absorption of hydrophobic and hydrophilic drugs using quaternary ammonium palmitoyl glycol chitosan nanoparticles. Mol Pharm

Enkephalin glycopeptide analogues produce analgesia with reduced dependence liability.

Entry of EGF into brain is rapid and saturable. Peptides

Evaluation of neuropeptide loaded trimethyl chitosan nanoparticles for nose to brain delivery.

Event-related brain potentials and working memory function in healthy humans after single-dose and prolonged intranasal administration of adrenocorticotropin 4-10 and desacetyl-alpha-melanocyte stimulating hormone.

Evolutionary combinatorial chemistry, a novel tool for SAR studies on peptide transport across the blood-brain barrier. Part 2. Design, synthesis and evaluation of a first generation of peptides.

Exploring uptake mechanisms of oral nanomedicines using multimodal nonlinear optical microscopy.

High transcytosis of melanotransferrin (P97) across the blood-brain barrier.

Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma.

Human blood-brain barrier insulin-like growth factor receptor. Metabolism

Identification and design of peptides as a new drug delivery system for the brain. J Pharmacol Exp Ther

Impaired transport of leptin across the blood-brain barrier in obesity is acquired and reversible.

Improved bioavailability to the brain of glycosylated Metenkephalin analogs. Brain Res

Improved brain uptake and pharmacological activity of dalargin using a peptide-vector-mediated strategy.

Improving the Endosomal Escape of Cell-Penetrating Peptides and Their Cargos: Strategies and Challenges. Pharmaceuticals

In vitro and in vivo studies on gelatin-siloxane nanoparticles conjugated with SynB peptide to increase drug delivery to the brain.

In vivo inhibition of Abeta production by memapsin 2 (betasecretase) inhibitors.

Insulin-binding sites in the rat brain: in vivo localization to the circumventricular organs by quantitative radioautography. Endocrinology

Interaction of HIV-1 Tat protein with heparin.

Intestinal and blood-brain drug transport: beyond involvement of a single transport function. Drug Discovery Today: Technologies

Intranasal angiotensin II directly influences central nervous regulation of blood pressure.

Intranasal delivery of cell-penetrating anti-NF-κB peptides (Tat-NBD) alleviates infection-sensitized hypoxic-ischemic brain injury. Exp Neurol

Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Neurology

Intranasal insulin improves memory in humans. Psychoneuroendocrinology

Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders.

Intranasal serum insulin levels in healthy men. Diabetes

Intravenous human interleukin-1alpha impairs memory processing in mice: dependence on blood-brain barrier transport into posterior division of the septum. J Pharmacol Exp Ther

Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2.

Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration. Biomaterials

Lactoferrin: molecular structure and biological function. Annu Rev Nutr.

Leptin access into the brain: A saturated transport mechanism in obesity. Physiol Behav

Leptin transport across the blood-brain barrier: implications for the cause and treatment of obesity. Curr Pharm Des

Mammalian lactoferrin receptors: structure and function. Cell Mol Life Sci.

Morphologic characterization of the pathway of transferrin endocytosis and recycling in human KB cells.

Nanofiber-based delivery of therapeutic peptides to the brain.

Nanomedicines and nanodiagnostics come of age.

Nanoparticle-mediated delivery of neurotoxin-II to the brain with intranasal administration: an effective strategy to improve antinociceptive activity of neurotoxin. Drug Dev Ind Pharm

Nanoparticles for Brain Drug Delivery.

NAP and D-SAL:neuroprotection against the beta amyloid peptide (1−42).

Neuropeptides: general characteristics and neuropharmaceutical potential in treating CNS disorders.

Opposite direction of transport across the blood-brain barrier for TyrMIF-1 and MIF-1: comparison with morphine. Peptides

Overweight humans are resistant to the weight-reducing effects of melanocortin 4-10.

Oxytocin attenuates amygdala reactivity to fear in generalised social anxiety disorder.

Oxytocin improves “mind-reading” in humans.

Oxytocin increases trust in humans. Nature

Oxytocin modulates neural circuitry for social cognition and fear in humans.

Penetratin-functionalized PEG-PLA nanoparticles for brain drug delivery.

Peptide-based vectors for blood-brain barrier targeting and delivery of drugs to the central nervous system. Ther Deliv

Pharm Biopharm

Pharmacokinetics and brain uptake of lactoferrin in rats. Life Sci

Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs. Pharm Res

https://researchportal.port.ac.uk/portal/services/downloadRegister/1811036/Lalatsa_Strategies_to_Deliver_Peptide_Drugs_to_the_Brain_2014.pdf

Strategies to deliver peptide drugs to the brain

Abstract

Similar works

Full text

Available Versions

Name not available

Portsmouth University Research Portal (Pure)